Chemical Works of Gedeon Richter (BUD:RICHTER) Net Income From Continuing Operations

: Ft171,540 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Chemical Works of Gedeon Richter's net income from continuing operations for the three months ended in Dec. 2023 was Ft41,291 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was Ft171,540 Mil.

Chemical Works of Gedeon Richter Net Income From Continuing Operations Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

50,848.00

115,164.00

146,575.00

165,663.00

171,540.00

Chemical Works of Gedeon Richter Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations																-43,741.00	37,996.00	34,858.00	57,395.00	41,291.00

Chemical Works of Gedeon Richter Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft171,540 Mil.

Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

RGEDF:USA GEDSF:USA 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines